Leap Therapeutics (LPTX) jumped about 300% after disclosing a $50 million purchase of Zcash (ZEC) at roughly $454.92 per coin, following a $58.9 million raise led by Winklevoss Capital. The former biotech has completed a rapid pivot to a digital treasury strategy.
Leap Therapeutics shares jumped about 170% on Nov. 12 after the company announced a pivot to a crypto-focused strategy and a $50 million purchase of Zcash (ZEC). The transaction is reportedly backed by Winklevoss Capital.